Pharmacologic evaluation of gentamicin in newborn infants.
D000367:Age Factors; D001424:Bacterial Infections / Q000188:drug therapy*; D001835:Body Weight; D002493:Central Nervous System Diseases / Q000188:drug therapy; D005319:Fetal Hemoglobin / Q000494:pharmacology; D005839:Gentamicins / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D005919:Glomerular Filtration Rate; D006207:Half-Life; D006801:Humans; D006849:Hydrocephalus / Q000150:complications; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008581:Meningitis / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D016135:Spinal Dysraphism / Q000150:complications; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy
D005839:Gentamicins; D005319:Fetal Hemoglobin